{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:15:01Z","timestamp":1764688501608,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.ejca.2005.12.018","type":"journal-article","created":{"date-parts":[[2006,3,16]],"date-time":"2006-03-16T07:17:02Z","timestamp":1142493422000},"page":"934-947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel"],"prefix":"10.1016","volume":"42","author":[{"given":"L.S.","family":"Faried","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Faried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kuwano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Minegishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"article-title":"Globocan 2000: Cancer incidence, mortality, and prevalence worldwide","year":"2001","author":"Ferlay","key":"10.1016\/j.ejca.2005.12.018_bib1"},{"key":"10.1016\/j.ejca.2005.12.018_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M","article-title":"Estimates of the worldwide mortality from 25 cancers in 1990","volume":"83","author":"Pisani","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2005.12.018_bib3","first-page":"27","article-title":"Current status of chemotherapy for cancer of the cervix","volume":"6","author":"Omura","year":"1992","journal-title":"Oncology"},{"key":"10.1016\/j.ejca.2005.12.018_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.med.48.1.353","article-title":"The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents","volume":"48","author":"Rowinsky","year":"1997","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ejca.2005.12.018_bib5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1200\/JCO.1996.14.3.792","article-title":"Paclitaxel has moderate activity in squamous cervix cancer: a Gynecologic Oncology Group study","volume":"14","author":"McGuire","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.12.018_bib6","first-page":"2486","article-title":"Phase I clinical and pharmacokinetics study of taxol","volume":"47","author":"Wiernik","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.12.018_bib7","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2004.04.170","article-title":"Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study","volume":"22","author":"Moore","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.12.018_bib8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.1999.17.3.761","article-title":"Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix","volume":"17","author":"Papadimitriou","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.12.018_bib9","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1200\/JCO.1999.17.9.2676","article-title":"Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"17","author":"Rose","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.12.018_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0955-0674(98)80095-1","article-title":"Microtubules and actin filaments: dynamics target for cancer chemotherapy","volume":"10","author":"Jordan","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ejca.2005.12.018_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-2776(08)60402-2","article-title":"CD95 (APO-1\/Fas)-mediated apoptosis: live and let die","volume":"71","author":"Krammer","year":"1999","journal-title":"Adv Immunol"},{"key":"10.1016\/j.ejca.2005.12.018_bib12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1357-2725(00)00048-0","article-title":"Regulation of death receptor-mediated apoptosis pathways","volume":"32","author":"Schmitz","year":"2000","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ejca.2005.12.018_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc776","article-title":"Death and anti-death: tumour resistance to apoptosis","volume":"2","author":"Igney","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2005.12.018_bib14","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejca.2005.12.018_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","article-title":"Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade","volume":"91","author":"Li","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2005.12.018_bib16","doi-asserted-by":"crossref","first-page":"16720","DOI":"10.1074\/jbc.271.28.16720","article-title":"ICE-LAP6, a novel member of the ICE\/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B","volume":"271","author":"Duan","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.12.018_bib17","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1084\/jem.183.5.1957","article-title":"Apopain\/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic cell death","volume":"183","author":"Casciola-Rosen","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.ejca.2005.12.018_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1477-7827-1-66","article-title":"Chemoresistance in human ovarian cancer: the role of apoptotic regulators","volume":"1","author":"Fraser","year":"2003","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ejca.2005.12.018_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/428267a","article-title":"Cancer: survival pathways meet their end","volume":"428","author":"McCormick","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2005.12.018_bib20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jtcvs.2003.09.033","article-title":"Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase\/protein kinase B (Akt)","volume":"127","author":"Nguyen","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejca.2005.12.018_bib21","doi-asserted-by":"crossref","first-page":"33490","DOI":"10.1074\/jbc.M204042200","article-title":"Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel","volume":"277","author":"Mabuchi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.12.018_bib22","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jamcollsurg.2003.12.005","article-title":"Inhibition of AKT abrogates chemotherapy-induced NF\u03baB survival mechanisms: implications for therapy in pancreatic cancer","volume":"198","author":"Fahy","year":"2004","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejca.2005.12.018_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4161\/cbt.2.5.446","article-title":"Rhebbing of mTOR: new insight on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis","volume":"2","author":"Kwiatkowski","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ejca.2005.12.018_bib24","first-page":"3504","article-title":"A direct linkage between the phosphoinositide 3-kinase-AKT signalling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells","volume":"60","author":"Sekulic","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2005.12.018_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/stke.2122003re15","article-title":"TOR signalling","author":"Harris","year":"2003","journal-title":"Science STKE"},{"key":"10.1016\/j.ejca.2005.12.018_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00280-005-0038-z","article-title":"Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines","volume":"57","author":"Faried","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ejca.2005.12.018_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J Immunol Meth"},{"key":"10.1016\/j.ejca.2005.12.018_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.biochem.69.1.217","article-title":"Apoptosis signalling","volume":"69","author":"Strasser","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ejca.2005.12.018_bib29","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-\u03baB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2005.12.018_bib30","first-page":"317","article-title":"Adenovirus-mediated inhibition of NF-\u03baB confers chemosensitization and apoptosis in prostate cancer cells","volume":"23","author":"Flynn","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ejca.2005.12.018_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1101\/gad.13.3.239","article-title":"IAP family proteins\u2013suppressors of apoptosis","volume":"13","author":"Deveraux","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.ejca.2005.12.018_bib32","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/emboj\/17.8.2215","article-title":"IAPs block apoptosis events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases","volume":"17","author":"Deveraux","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.ejca.2005.12.018_bib33","first-page":"1739","article-title":"5-Fluorouracil interferes with paclitaxel cytotoxicity against human solid tumor cells","volume":"3","author":"Johnson","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2005.12.018_bib34","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.bjc.6600788","article-title":"Reversal of Taxol resistance in hepatoma by cyclosporin A: involvement of the PI-3 kinase-AKT1 pathway","volume":"88","author":"Lin","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2005.12.018_bib35","first-page":"407","article-title":"Overexpression of Akt\/AKT can modulate chemotherapy-induced apoptosis","volume":"20","author":"Page","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2005.12.018_bib36","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.ejca.2005.12.018_bib37","doi-asserted-by":"crossref","first-page":"42628","DOI":"10.1074\/jbc.M405173200","article-title":"In rat hepatocytes glucagons increases mammalian target of rapamycin phosphorylation on serine 2448 but antagonizes the phosphorylation of its downstream targets induced by insulin and amino acids","volume":"279","author":"Mothe-Satney","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.12.018_bib38","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1096\/fj.03-1409fje","article-title":"Amino acids and leucine allow insulin activation of the PKB\/mTOR pathway in normal adipocytes treated with wortmannin and in adipocytes from db\/db mice","volume":"18","author":"Hinault","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.ejca.2005.12.018_bib39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/1097-4644(20001201)79:3<427::AID-JCB80>3.0.CO;2-0","article-title":"Assessment of cell-signalling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes","volume":"79","author":"Pham","year":"2000","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ejca.2005.12.018_bib40","doi-asserted-by":"crossref","first-page":"19937","DOI":"10.1074\/jbc.M411865200","article-title":"The mammalian target of rapamycin-p70 ribosomal S kinase but not phosphatidylinositol 3-kinase-Akt signalling is responsible for fibroblast growth factor-9-induced cell proliferation","volume":"280","author":"Wing","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2005.12.018_bib41","first-page":"971","article-title":"Translation initiation in cancer: a novel target for therapy","volume":"1","author":"Meric","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ejca.2005.12.018_bib42","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1158\/1078-0432.CCR-04-0361","article-title":"Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells","volume":"10","author":"Mondesire","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2005.12.018_bib43","doi-asserted-by":"crossref","first-page":"9666","DOI":"10.1073\/pnas.171301998","article-title":"p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule Bad","volume":"98","author":"Harada","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2005.12.018_bib44","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/MCB.22.8.2853-2861.2002","article-title":"Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency","volume":"22","author":"Li","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ejca.2005.12.018_bib45","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1128\/MCB.22.6.1674-1683.2002","article-title":"Caspase cleavage of initiation factor 4E-binding protein I yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif","volume":"22","author":"Tee","year":"2002","journal-title":"Mol Cell Biol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804906000992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804906000992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:16:00Z","timestamp":1760732160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804906000992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0959804906000992"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2005.12.018","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2005.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}